Antonio Oliver spends much of his time researching Microbiology, Pseudomonas aeruginosa, Antibiotics, Antibacterial agent and Antibiotic resistance. His Microbiology study combines topics in areas such as Beta-lactamase and Multilocus sequence typing, Genotype. His study in Pseudomonas aeruginosa is interdisciplinary in nature, drawing from both Multiple drug resistance, Drug resistance and Integron.
His work carried out in the field of Antibiotics brings together such families of science as Intensive care medicine, Cystic fibrosis, Combination therapy and Biofilm. Antonio Oliver combines subjects such as Plasmid, Nucleic acid sequence and Escherichia coli with his study of Antibacterial agent. The study incorporates disciplines such as Microbial resistance and Proa in addition to Antibiotic resistance.
Antonio Oliver mostly deals with Microbiology, Pseudomonas aeruginosa, Antibiotic resistance, Antibiotics and Ceftazidime. Microbiology connects with themes related to Biofilm in his study. His Pseudomonas aeruginosa research includes themes of Multiple drug resistance, Cystic fibrosis, Mutant and Virulence.
His Antibiotic resistance research is multidisciplinary, incorporating perspectives in Ciprofloxacin, Respiratory infection and Genotype. Antonio Oliver has researched Antibiotics in several fields, including Antimicrobial, Bacteria, Efflux, Combination therapy and Klebsiella pneumoniae. His Ceftazidime research incorporates elements of Tazobactam and Cephalosporin.
His main research concerns Pseudomonas aeruginosa, Microbiology, Antibiotics, Antibiotic resistance and Ceftolozane. The study incorporates disciplines such as Multiple drug resistance, Pathogen, Phenotype, Genome and Virulence in addition to Pseudomonas aeruginosa. Antonio Oliver has included themes like Ceftazidime and Multilocus sequence typing in his Microbiology study.
The concepts of his Antibiotics study are interwoven with issues in Mutation, Efflux, Cystic fibrosis and Biofilm. His biological study spans a wide range of topics, including Lactam and Ciprofloxacin. His research investigates the connection between Ceftolozane and topics such as Tazobactam that intersect with issues in Broth microdilution, Drug resistance, Respiratory tract infections and Amikacin.
The scientist’s investigation covers issues in Pseudomonas aeruginosa, Microbiology, Antibiotics, Antibiotic resistance and Multiple drug resistance. Antonio Oliver combines subjects such as Phenotype, Antimicrobial, Clone, Combination therapy and Drug resistance with his study of Pseudomonas aeruginosa. The Microbiology study combines topics in areas such as Lactam and Multilocus sequence typing.
His work deals with themes such as Internal medicine and Cystic fibrosis, which intersect with Antibiotics. His Antibiotic resistance research integrates issues from Biofilm, Mutation, Gene, Mutant and Whole genome sequencing. His Multiple drug resistance study incorporates themes from Klebsiella pneumoniae and Acinetobacter baumannii.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Antonio Oliver;Rafael Cantón;Pilar Campo;Fernando Baquero.
Science (2000)
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Marina Pollán;Beatriz Pérez-Gómez;Roberto Pastor-Barriuso;Jesús Oteo.
The Lancet (2020)
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
N. Høiby;T. Bjarnsholt;C. Moser;G. L. Bassi.
Clinical Microbiology and Infection (2015)
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Jesús Rodríguez-Baño;Juan C. Alcalá;Jose M. Cisneros;Fabio Grill.
JAMA Internal Medicine (2008)
The increasing threat of Pseudomonas aeruginosa high-risk clones.
Antonio Oliver;Xavier Mulet;Carla López-Causapé;Carlos Juan.
Drug Resistance Updates (2015)
OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain
Germán Bou;Antonio Oliver;Jesús Martínez-Beltrán.
Antimicrobial Agents and Chemotherapy (2000)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh.
Lancet Infectious Diseases (2017)
Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesuús Rodríguez-Baño;Encarnación Picón;Paloma Gijón;José Ramón Hernández.
Clinical Infectious Diseases (2010)
Antimicrobial susceptibility testing in biofilm-growing bacteria
M.D. Macia;E. Rojo-Molinero;A. Oliver.
Clinical Microbiology and Infection (2014)
Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance in Pseudomonas aeruginosa Strains Causing Chronic Lung Infections
María D. Maciá;David Blanquer;Bernat Togores;Jaume Sauleda.
Antimicrobial Agents and Chemotherapy (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of the Balearic Islands
Instituto Ramón y Cajal de Investigación Sanitaria
University of A Coruña
University of Córdoba
University of Seville
University of Seville
Autonomous University of Barcelona
Bellvitge University Hospital
Instituto de Salud Carlos III
Hospital General Universitario Gregorio Marañón
Carleton University
Arizona State University
University of Toronto
University of Florence
University at Buffalo, State University of New York
University of Guelph
Ames Laboratory
University of Queensland
Lehigh University
University of Sheffield
University of Genoa
Ghent University
ETH Zurich
University of Maryland, Baltimore
University of Porto
Technical University of Munich